Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Safety of DWJ1392 and DWC20164 in Healthy Volunteers
NCT03016520Phase 1Unknown
- Sponsor
- Daewoong Pharmaceutical
- Start
- Jan 2017
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of DWJ1392 (2 arms), sponsored by Daewoong Pharmaceutical. Primary endpoints: Maximum Plasma Concentration and Area Under the Curve. Status: unknown.
02
Drugs
DWJ1392
Beyond the preview
Go deeper on NCT03016520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03016520.